Cite
Jiao XD, Ding LR, Zhang CT, et al. Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma. Transl Lung Cancer Res. 2021;10(7):3236-3250doi: 10.21037/tlcr-21-543.
Jiao, X. D., Ding, L. R., Zhang, C. T., Qin, B. D., Liu, K., Jiang, L. P., Wang, X., Lv, L. T., Ding, H., Li, D. M., Yang, H., Chen, X. Q., Zhu, W. Y., Wu, Y., Ling, Y., He, X., Liu, J., Shao, L., Wang, H. Z., Chen, Y., Zheng, J. J., Inui, N., & Zang, Y. S. (2021). Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma. Translational lung cancer research, 10(7), 3236-3250. https://doi.org/10.21037/tlcr-21-543
Jiao, Xiao-Dong, et al. "Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma." Translational lung cancer research vol. 10,7 (2021): 3236-3250. doi: https://doi.org/10.21037/tlcr-21-543
Jiao XD, Ding LR, Zhang CT, Qin BD, Liu K, Jiang LP, Wang X, Lv LT, Ding H, Li DM, Yang H, Chen XQ, Zhu WY, Wu Y, Ling Y, He X, Liu J, Shao L, Wang HZ, Chen Y, Zheng JJ, Inui N, Zang YS. Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma. Transl Lung Cancer Res. 2021 Jul;10(7):3236-3250. doi: 10.21037/tlcr-21-543. PMID: 34430361; PMCID: PMC8350084.
Copy
Download .nbib